Education
About Us
Working with TipRanks
Follow Us
Michael Kaswan Insider Profile
4 Followers
Michael Kaswan, COO, Director at Summer Infant, holds 400.00K shares in Summer Infant (Ticker: SUMR), holds 162.57K shares in Orchestra BioMed Holdings (Ticker: OBIO). Most recently, Michael Kaswan ― shares of Summer Infant on ― for an estimated value of ―.
Michael Kaswan Summer Infant (SUMR)COO, Director
Summer Infant (SUMR)
COO, Director
Not Ranked
Michael Kaswan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CFO
Roles that Michael Kaswan holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Michael Kaswan
Michael Kaswan's Trading History
Summer Infant
―
―
―
$4.80M
Orchestra BioMed Holdings
May 05, 2023
CFO
Uninformative Buy
643.86K
$687.69K
List of latest transactions for each holding click on a transaction to see Michael Kaswan's performance on stock
You May Also Like
Michael Kaswan insider profile FAQ
What is the percentage of profitable transactions made by Michael Kaswan?
The percentage of profitable transactions made by Michael Kaswan is ―.
What is the average return per transaction made by Michael Kaswan?
The average return per transaction made by Michael Kaswan is ―.
What stocks does Michael Kaswan hold?
Michael Kaswan holds: SUMR, OBIO stocks.
What was Michael Kaswan’s latest transaction?
Michael Kaswan latest transaction was an Uninformative Buy of ―.
What was Michael Kaswan's most profitable transaction?
Michael Kaswan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Michael Kaswan's role in Summer Infant?
Michael Kaswan's role in Summer Infant is COO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.